CNN's Panel on Antisemitism Was a Total Trainwreck
Reporter Gave a Laughable Reason for Why We Can't Trust Polls Now
I'm Not So Sure Bill Clinton Is the Person to Lead Point on...
CBS News' Margaret Brennan Got Wrecked By Scott Bessent and Marty Makary Over...
Watch Scott Jennings Obliterate a Reporter Over Her 'Both Sides' Nonsense on Political...
The Democrats Are the Party of Antisemitic Terrorism
If Democrats Had the Truth on Their Side They Wouldn’t Have to Lie...
Jewish Americans Can No Longer Afford to Be Unarmed
Sanctuary States, Sleeper Cells, and a Nation on the Brink
White House Shuts Down One of the 'Most Disgusting Lies' Being Spread About...
Hey You, Get Off My Crowd
Hey You, Get Off of My Crowd
Marco Rubio Has a Warning for 'All Terrorists'
This Transgender Athlete Shared This Flippant Response After Dominating a Women's Race
Republicans Could Make History on Gun Rights
Tipsheet

FDA Makes Announcement About J&J Vaccine

AP Photo/Matt Rourke

The Food and Drug Administration announced Thursday that it is limiting the emergency use authorization of the Johnson & Johnson Covid-19 vaccine to people who either cannot or will not take other vaccines, citing the risk of thrombocytopenia syndrome (TTS).

Advertisement

“After conducting an updated analysis, evaluation and investigation of reported cases, the FDA has determined that the risk of thrombosis with thrombocytopenia syndrome (TTS), a syndrome of rare and potentially life-threatening blood clots in combination with low levels of blood platelets with onset of symptoms approximately one to two weeks following administration of the Janssen COVID-19 Vaccine, warrants limiting the authorized use of the vaccine,” FDA said in a statement.

Individuals 18 years of age or older who had a severe reaction to the Pfizer or Moderna Covid-19 vaccines or who do not have access to these shots may still receive the J&J jab. Additionally, people who would otherwise not be inoculated at all if they cannot receive the J&J shot may still get it.

“We recognize that the Janssen COVID-19 Vaccine still has a role in the current pandemic response in the United States and across the global community. Our action reflects our updated analysis of the risk of TTS following administration of this vaccine and limits the use of the vaccine to certain individuals,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research, in a statement. “Today’s action demonstrates the robustness of our safety surveillance systems and our commitment to ensuring that science and data guide our decisions.”

Advertisement

 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement